S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
Teva Pharmaceutical Industries Ltd. announced that S&P Global Ratings has upgraded its long-term issuer credit rating from BB+ to BBB-, marking the third credit upgrade in recent months from major rating agencies. This upgrade reflects Teva's strong execution of its Pivot to Growth strategy, significant debt reduction, and financial strengthening, …